Provided by Tiger Fintech (Singapore) Pte. Ltd.

Beyond Air, Inc.

0.2686
+0.01807.18%
Post-market: 0.2614-0.0072-2.68%19:37 EDT
Volume:1.44M
Turnover:366.12K
Market Cap:23.71M
PE:-0.28
High:0.2709
Open:0.2490
Low:0.2400
Close:0.2506
Loading ...

Company Profile

Company Name:
Beyond Air, Inc.
Exchange:
NASDAQ
Establishment Date:
2011
Employees:
107
Office Location:
900 Stewart Avenue,Suite 301,Garden City,New York,United States
Zip Code:
11530
Fax:
- -
Introduction:
Beyond Air, Inc. operates as a commercial-stage medical device and biopharmaceutical company in the United States. The company engages in the development of LungFit platform, a nitric oxide generator and delivery system. It offers LungFit PH for the treatment of persistent pulmonary hypertension of the newborn. The company is also developing LungFit PRO for the treatment of viral lung infections, such as community-acquired viral pneumonia, including COVID-19, as well as bronchiolitis in hospitalized patients; and LungFit GO for the treatment of nontuberculous mycobacteria. The company was formerly known as AIT Therapeutics, Inc. and changed its name to Beyond Air, Inc. in June 2019. Beyond Air, Inc. is based in Garden City, New York.

Directors

Name
Position
Steven A. Lisi
Chief Executive Officer and Chairman of the Board
Amir Avniel
President, Chief Business Officer and Director
Erick Lucera
Director
Robert F. Carey
Director
Ron Bentsur
Director
William Forbes
Director
Yoori Lee
Director

Shareholders

Name
Position
Steven A. Lisi
Chief Executive Officer and Chairman of the Board
Michael Gaul
Chief Operating Officer
Douglas Larson
Chief Financial Officer
Amir Avniel
President, Chief Business Officer and Director
Jeff Myers
Chief Medical Officer